Stockreport

Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder [Yahoo! Finance]

Mind Medicine (MindMed) Inc. - Common Shares  (MNMD) 
PDF advancing traditional and innovative behavioral health treatments with a focus on safe, evidence-based novel therapies, congratulates Mind Medicine ("MindMed" NASDAQ: MN [Read more]